Eoin J.
- Country
- Ireland
- Department
- Respiratory Department / Research
Research Overview
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Idiopathic Pulmonary Fibrosis
- A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Admilparant in Participants with Progressive Pulmonary Fibrosis
- Long-term Safety and Efficacy Evaluation of Oral BI 1015550 in Patients with Idiopathic and Progressive Pulmonary Fibrosis
Data & Insights
Has run more than one trial at 123 of 296 partner sites.
Specializations
Respiratory Disease Specialization
This investigator focuses on treating patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), conducting research into innovative therapeutic approaches for these challenging respiratory conditions.
- Pulmonary Fibrosis Management
- Long-term Disease Monitoring
- Chronic Respiratory Care
The investigator evaluates novel treatment options for patients with fibrosing lung diseases.
Therapeutic Assessment
The investigator specializes in evaluating the long-term tolerability and safety of new therapeutic agents for pulmonary fibrosis, with particular attention to sustained treatment outcomes.
- Treatment Safety Evaluation
- Clinical Response Assessment
- Patient Monitoring Protocols
Their work encompasses comprehensive assessment of therapeutic interventions in respiratory medicine.
Clinical Expertise
The investigator's clinical focus includes advanced respiratory therapeutics and the management of progressive lung conditions, particularly in patients with established pulmonary fibrosis diagnoses.
- Disease Progression Monitoring
- Therapeutic Response Evaluation
- Long-term Patient Care
Their expertise extends to monitoring treatment efficacy in chronic respiratory conditions.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.